Suzhou FujiLife Pharmaceutical Co., Ltd. is a joint-stock limited company (unlisted, natural person invested or controlled) incorporated on 2000-11-27 in Suzhou, Jiangsu Province, with its registered address at No. 16, Haiwang Road, Changshu New Material Industrial Park, Jiangsu Province.
Suzhou FujiLife Pharmaceuticals Co., Ltd.'s unified social credit code / registration number is 913205007205525400, the enterprise's legal person Qian Xiangyun, the enterprise is currently in the state of opening.
Suzhou Fujilai Pharmaceutical Co., Ltd. is engaged in the following business scope: production and sale of: ethyl 6,8-dichlorooctanoate, lipoic acid and derivatives, L-creatinine and derivatives, glycerophosphatidylcholine, phosphatidylcholine, lipoic acid amide, erliximab, apatinib; sale of by-products of the production of: sodium sulfite, polymerization of aluminum chloride, ammonia (≤ 10%), bis(ketopropoxy)zine; retail production of By-products: industrial salt (NaCl content ≥ 96%); self-supporting and acting as an agent for the import and export of all kinds of commodities and technologies (except for those commodities and technologies that are restricted or prohibited by the state). (Items subject to approval in accordance with the law, can only carry out business activities after approval by the relevant departments). In Jiangsu Province, the total registered capital of companies with similar business scope is 2892,621,000 yuan, with the main capital concentrated in enterprises with a scale of 10-50 million and 50 million or more, ****1,165 companies. Within this province, the current registered capital of enterprises is excellent.
Through Baidu Enterprise Credit to view more information and information about Suzhou Fuji Lai Pharmaceutical Co.